Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. cannabinoid product
Show results for
Products
Services

Companies

News
Articles
Videos

Refine by
Date

  • Older

Cannabinoid Product Articles & Analysis

17 news found

InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector

InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector

“THCV is one of the few rare cannabinoids that has been researched in early clinical trials for various therapeutic effects, fueling significant interest by end-product manufacturers and consumers alike. ...

ByInMed Pharmaceuticals Inc.


An Overview of Glioblastoma

An Overview of Glioblastoma

Endocannadinoids natural role in the body is communication between cells. Cannabinoids and Radiation – Recent research from Columbia University shows that cannabinoids, a class of chemicals best known because of their presence in cannabis, may be able to enhance the effectiveness of radiotherapy. ...

ByDiverse Biotech Inc


Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBD

Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBD

("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development today announced that the European Medicines Agency (EMA) has classified PPP004 as an orphan medicinal product for the treatment for epidermolysis bullosa (EB). ...

ByTetra Bio-Pharma


Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology

Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology

Panag Pharma Inc (Panag), a subsidiary of Tetra Bio-Pharma, will collect royalties on sales on products produced with the technology True North has licensed from Panag. ...

ByTetra Bio-Pharma


Tetra Bio-Pharma Enters into a Strategic Partnership with Avicanna

Tetra Bio-Pharma Enters into a Strategic Partnership with Avicanna

"We look forward to collaborating with the Tetra team who has in many ways been pioneering cannabinoid- prescription products. As the global industry continues to mature and shift its focus towards evidence-based medicines, the two companies are well positioned to work in synergy across several projects and leverage their leadership positions into fruitful ...

ByTetra Bio-Pharma


Tetra Bio-Pharma Announces Closing of $2.1 Million Marketed Public Offering of Units

Tetra Bio-Pharma Announces Closing of $2.1 Million Marketed Public Offering of Units

("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development, is pleased to announce the closing of its marketed public offering (the "Offering") of 13,064,000 units of the Company (the "Units"), at a price of $0.163 per Unit for aggregate gross proceeds of $2.1 million. ...

ByTetra Bio-Pharma


Tetra Bio-Pharma Announces Positive Initial Clinical Data from Both of its Ongoing Phase 2 Clinical Trials of QIXLEEF™

Tetra Bio-Pharma Announces Positive Initial Clinical Data from Both of its Ongoing Phase 2 Clinical Trials of QIXLEEF™

("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development today announced positive initial clinical data from its ongoing Phase 2 clinical trials (REBORN©1 and PLENITUDE©) of QIXLEEF™ for cancer pain. ...

ByTetra Bio-Pharma


QIXLEEF™ Aerosol Meets the Criteria Established by the U.S. FDA for Delivery of Inhalation Aerosols

QIXLEEF™ Aerosol Meets the Criteria Established by the U.S. FDA for Delivery of Inhalation Aerosols

Meeting the DDU specification is critical for a quality inhaled drug product. Earlier this year, Tetra announced it received from the Malta Medicines Authority (MAA) a Scientific Advice Assessment (SAA) Report. ...

ByTetra Bio-Pharma


CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health

CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health

Customers and patients can register at info@canaqueststore.com for updates on product developments. CanaQuest is entering discussions with domestic and international medical cannabis distributors. ...

ByCanaQuest Medical Corp.


CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications

CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications

Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced that Rob Rinderman has joined CanaQuest as its new Director of Communications. ...

ByCanaQuest Medical Corp.


CanaQuest Medical Corp Honored With International CBD Life Science R & D Excellence Award 2020 by Global Health & Pharma

CanaQuest Medical Corp Honored With International CBD Life Science R & D Excellence Award 2020 by Global Health & Pharma

CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the “Company” or “CanaQuest“), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced it has been awarded the International CBD Life Science R & D Excellence Award 2020 by Global ...

ByCanaQuest Medical Corp.


Fundamental Research Corp Initiates Coverage on CanaQuest (CANQF) with Buy Rating and US$0.78 Fair Value Estimate

Fundamental Research Corp Initiates Coverage on CanaQuest (CANQF) with Buy Rating and US$0.78 Fair Value Estimate

Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced that Fundamental Research Corp (“FRC”), one of the world’s largest independent ...

ByCanaQuest Medical Corp.


CanaQuest Signs Medicinal Cannabis Education Partnership with the Canadian Cannabis Dispute Resolution Centre

CanaQuest Signs Medicinal Cannabis Education Partnership with the Canadian Cannabis Dispute Resolution Centre

Canaquest Medical Corp (OTC Markets: “CANQF”) (the “Company” or “CanaQuest”), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), is pleased to announce its new partnership with the Canadian Cannabis Dispute Resolution Centre ...

ByCanaQuest Medical Corp.


Cannabis Sequencing and New Cancer Research

Cannabis Sequencing and New Cancer Research

Strains of Cannabis With High CBD Levels Cannabis is a multi-purpose plant that produces fiber, edible seed, oil and numerous cannabinoids such as THC, CBD, CBN. It is also unique in that no other plants are known to have the ability to produce cannabinoids. ...

ByDiverse Biotech Inc


The Importance of DNA Sequencing and Cancer Research

The Importance of DNA Sequencing and Cancer Research

Diverse Biotech Inc. is an innovative, clinical-stage biopharmaceutical research company, committed to discovering and developing novel therapeutics from its proprietary cannabinoid product platform. ...

ByDiverse Biotech Inc


CBD May Slow Cancer Growth

CBD May Slow Cancer Growth

According to the American Cancer Society, scientists have recently reported that THC and other cannabinoids such as CBD slow growth and/or cause death in certain types of cancer cells growing in lab dishes. ...

ByDiverse Biotech Inc


Current Treatment Options and Research for Glioblastoma

Current Treatment Options and Research for Glioblastoma

One particular area of study includes the use of a cannabinoid called cannabidiol (CBD). Early studies are indicating that this particular substance in marijuana may improve glioblastoma treatment. ...

ByDiverse Biotech Inc

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT